OcuMension secures Alcon eye drop rights with 16.7% stake, marking major strategic shift
OcuMension Therapeutics has struck a landmark deal with Alcon Inc., acquiring commercialization rights for a portfolio of eye care products in China. In exchange, OcuMension ... Read More